BioAtla BCAB
NASDAQ BCAB
$3.18 +0.00 (+0.00%)
As of: Aug 21, 2026 · 3:59 PM EDT

BioAtla (BCAB) Non Operating Income (2021 - 2024)

BioAtla (BCAB) posted quarterly Non Operating Income of -$1000.0 for Q4 2024, up 96.3% year-over-year from -$509.43 in Q1 2024, and up 87.5% quarter-over-quarter from -$8000.0 in Q3 2024.

BioAtla (BCAB) Non Operating Income (2021 - 2024) Analysis & Trends

BioAtla's Non Operating Income history runs 4 years deep, the most recent figure standing at -$1000.0 for Q4 2024.

  • In Q4 2024, Non Operating Income rose 96.3% year-over-year to -$1000.0; the TTM figure through Dec 2024 stood at -$9000.0 (up 89.66% YoY), while the FY2025 annual figure was -$1.0 million, down 11388.89% from the prior year.
  • Non Operating Income for Q4 2024 stood at -$1000.0, up from -$8000.0 in the prior quarter.
  • The five-year high for Non Operating Income was $30000.0 in Q3 2022, with the low at -$39000.0 in Q3 2023.
  • The 4-year median for Non Operating Income is -$4500.0 (2021), against an average of -$7083.3.
  • Peak annual rise in Non Operating Income reached 3100.0% in 2022, while the deepest fall reached 1600.0% in 2022.
  • BioAtla's Non Operating Income stood at $2000.0 in 2021, then sank by 1600.0% to -$30000.0 in 2022, then climbed by 10.0% to -$27000.0 in 2023, then jumped by 96.3% to -$1000.0 in 2024.
  • Business Quant data shows BCAB's Non Operating Income at -$1000.0 in Q4 2024, -$8000.0 in Q3 2024, and -$27000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 234.30 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -53.64 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -51.63 Mn
10 BioAtla 5.41 Mn 5.41 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -1,000.00
Sep 30, 2024 -8,000.00
Dec 31, 2023 -27,000.00
Sep 30, 2023 -39,000.00
Jun 30, 2023 -11,000.00
Mar 31, 2023 -10,000.00
Dec 31, 2022 -30,000.00
Sep 30, 2022 30,000.00
Jun 30, 2022 3,000.00
Mar 31, 2022 7,000.00
Dec 31, 2021 2,000.00
Sep 30, 2021 -1,000.00